Devic`s disease – neuromyelitis optica Review article
Article Sidebar
Published:
Sep 30, 2014
Keywords:
neuromyelitis optica, multiple sclerosis, aquaporin 4
Main Article Content
Abstract
Neuromyelitis optica is a rare, acute inflammatory demyelinating disorder of the central nervous system formerly considered as a variant of multiple sclerosis. The discovery of specific autoantibodies reacting with aquaporin 4 and the development of diagnostic criteria revealed that neuromyelitis optica is disease with separate entity. Diagnosis of neuromyelitis optica requires considerable clinical experience, because initial symptoms may resemble multiple sclerosis. Although sometimes clinical manifestations of neuromyelitis optica are similar to multiple sclerosis, the clinical management is different. Therapy with interferon β, natalizumab and fingolimod, used in multiple sclerosis, in neuromyelitis optica can be disadventageous or even exacerbates symptoms of the disease.
Article Details
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Jacob A., Matiello M., Wingerchuk D.M. et al.: Neuromyelitis optica: changing concepts. J. Neuroimmunol. 2007; 187(1-2): 126-138.
2. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F. et al.: The spectrum of neuromyelitis optica. Lancet Neurol. 2007; 6(9): 805-815.
3. Lennon V.A., Wingerchuk D.M., Kryzer T.J. et al.: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364(9451): 2106-2112.
4. Wingerchuk D.M., Lennon V.A., Pittock S.J. et al.: Revised diagnostic criteria for neuromyelitis optica. Neurology 2011; 76(23): 2009.
5. Wingerchuk D.M., Lennon V.A., Pittock S.J. et al.: Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66(10): 1485-1489.
6. Papuć E., Miszczak E.: Diagnostyka różnicowa demielinizacji ośrodkowego układu nerwowego: poza granicami stwardnienia rozsianego. Neurol. Prakt. 3/2013. Tłumaczenie artykułu: Eickstein C., Saidha S., Levy M.: A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J. Neurol. 2012; 0259: 801-816.
7. Samei E.: Why medical image perception? J. Am. Coll. Radiol. 2006; 3: 400-401.
8. Sellner J., Boggild M., Clanet M. et al.: EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur. J. Neurol. 2010; 17(8): 1019-1032.
9. Jurewicz A.: Choroba Devica – nowe poglądy i nowe metody diagnostyczne. Polski Przegląd Neurologiczny 2010 (6) A.
10. Wingerchuk D.M., Hogancamp W.F., O’Brien P.C. et al.: The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999; 53(5): 1107-1114
11. Wingerchuk D.M., Weinshenker B.G.: Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica. Continuum (Minneap. Minn.). 2013; 4: 944-967.
12. Weinshenker B.G., Wingerchuk D.M., Vukusic S. et al.: Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 2006; 59(3): 566-569.
13. Papadopoulos M.C., Verkman A.S.: Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012; 11(6): 535-544.
14. Badaut J., Fukuda A.M., Jullienne A. et al.: Aquaporin and brain diseases. Biochim. Biophys. Acta 2014; 1840(5): 1554-1565.
15. Ratelade J., Verkman A.S.: Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int. J. Biochem. Cell. Biol. 2012; 44(9): 1519-1530.
16. Stwardnienie rozsiane. Interna Szczeklika. Członkowska A., Mirowska-Guzel D. (red.). Medycyna Praktyczna, Kraków 2012: 2079-2083.
17. Sato D.K., Callegaro D., Lana-Peixoto M.A. et al.: Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82(6): 474-481.
18. Eckstein C., Saidha S., Levy M.: A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J. Neurol. 2012; 259(5): 801-816.
19. Waters P.J., McKeon A., Leite M.I. et al.: Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012; 78(9): 665-671.
20. Jiao Y., Fryer J.P., Lennon V.A. et al.: Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2014; 71(1): 48-54.
21. Bergamaschi R., Tonietti S., Franciotta D. et al.: Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult. Scler. 2004; 10(1): 2-4.
22. Lepur D., Peterković V., Kalabrić-Lepur N.: Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis. Neurol. Sci. 2009; 30(1): 51-54.
23. Zaffaroni M., Italian Devic’s Study Group: Cerebrospinal fluid findings in Devic’s neuromyelitis optica. Neurol. Sci. 2004; 25: S368-370.
24. Trebst C., Jarius S., Berthele A. et al.; Neuromyelitis Optica Study Group (NEMOS): Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J. Neurol. 2014; 261(1): 1-16.
2. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F. et al.: The spectrum of neuromyelitis optica. Lancet Neurol. 2007; 6(9): 805-815.
3. Lennon V.A., Wingerchuk D.M., Kryzer T.J. et al.: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364(9451): 2106-2112.
4. Wingerchuk D.M., Lennon V.A., Pittock S.J. et al.: Revised diagnostic criteria for neuromyelitis optica. Neurology 2011; 76(23): 2009.
5. Wingerchuk D.M., Lennon V.A., Pittock S.J. et al.: Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66(10): 1485-1489.
6. Papuć E., Miszczak E.: Diagnostyka różnicowa demielinizacji ośrodkowego układu nerwowego: poza granicami stwardnienia rozsianego. Neurol. Prakt. 3/2013. Tłumaczenie artykułu: Eickstein C., Saidha S., Levy M.: A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J. Neurol. 2012; 0259: 801-816.
7. Samei E.: Why medical image perception? J. Am. Coll. Radiol. 2006; 3: 400-401.
8. Sellner J., Boggild M., Clanet M. et al.: EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur. J. Neurol. 2010; 17(8): 1019-1032.
9. Jurewicz A.: Choroba Devica – nowe poglądy i nowe metody diagnostyczne. Polski Przegląd Neurologiczny 2010 (6) A.
10. Wingerchuk D.M., Hogancamp W.F., O’Brien P.C. et al.: The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999; 53(5): 1107-1114
11. Wingerchuk D.M., Weinshenker B.G.: Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica. Continuum (Minneap. Minn.). 2013; 4: 944-967.
12. Weinshenker B.G., Wingerchuk D.M., Vukusic S. et al.: Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 2006; 59(3): 566-569.
13. Papadopoulos M.C., Verkman A.S.: Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012; 11(6): 535-544.
14. Badaut J., Fukuda A.M., Jullienne A. et al.: Aquaporin and brain diseases. Biochim. Biophys. Acta 2014; 1840(5): 1554-1565.
15. Ratelade J., Verkman A.S.: Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int. J. Biochem. Cell. Biol. 2012; 44(9): 1519-1530.
16. Stwardnienie rozsiane. Interna Szczeklika. Członkowska A., Mirowska-Guzel D. (red.). Medycyna Praktyczna, Kraków 2012: 2079-2083.
17. Sato D.K., Callegaro D., Lana-Peixoto M.A. et al.: Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82(6): 474-481.
18. Eckstein C., Saidha S., Levy M.: A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J. Neurol. 2012; 259(5): 801-816.
19. Waters P.J., McKeon A., Leite M.I. et al.: Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012; 78(9): 665-671.
20. Jiao Y., Fryer J.P., Lennon V.A. et al.: Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2014; 71(1): 48-54.
21. Bergamaschi R., Tonietti S., Franciotta D. et al.: Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult. Scler. 2004; 10(1): 2-4.
22. Lepur D., Peterković V., Kalabrić-Lepur N.: Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis. Neurol. Sci. 2009; 30(1): 51-54.
23. Zaffaroni M., Italian Devic’s Study Group: Cerebrospinal fluid findings in Devic’s neuromyelitis optica. Neurol. Sci. 2004; 25: S368-370.
24. Trebst C., Jarius S., Berthele A. et al.; Neuromyelitis Optica Study Group (NEMOS): Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J. Neurol. 2014; 261(1): 1-16.